Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020876 · ClinicalTrials.gov registry record
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations
A clinical trial, sponsored by GenomeDx Biosciences.
- Completed
- Registry status
- 21
- Enrollment target
NCT02020876: Completed study, sponsored by GenomeDx Biosciences.
NCT02020876 is a clinical trial that has completed, run by GenomeDx Biosciences. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020876 has completed, sponsored by GenomeDx Biosciences.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This clinical utility study pilot is based on a review of real but de-identified and randomized patient cases and aims to evaluate Urologists' treatment recommendations before and after reviewing the results provided by the Decipher test. This is a pilot study and the primary intent is to help guide development and design of future clinical utility studies for Decipher
Interventions
- OTHER DECIPHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02020876
The ClinicalTrials.gov registry entry for NCT02020876 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GenomeDx Biosciences, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DECIPHER Questionnaire is the first listed.
NCT02020876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02020876 about?
NCT02020876 is a clinical study titled "Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations". This clinical utility study pilot is based on a review of real but de-identified and randomized patient cases and aims to evaluate Urologists' treatment recommendations before and after reviewing the results provided by the Decipher test. This is a pilot study and the primary intent is to help guide...
What is the current status of trial NCT02020876?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2012-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02020876?
The interventions under investigation include: DECIPHER Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02020876?
This trial is sponsored by GenomeDx Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.